Loading...
Market
Which major pharmaceutical company will first partner for treatments using the single-cell atlas by end of 2025?
2
Resolution / Starting Odds
Pfizer • 25%
Johnson & Johnson • 25%
Novartis • 25%
Other • 25%
Official press releases from pharmaceutical companies or research institutions
Story
Nature Paper: First Single-Cell Atlas of Prenatal Human Skin Created, Offering New Insights
Oct 17, 2024, 08:06 AM
Researchers have created the first single-cell atlas of prenatal human skin, as detailed in a Nature research paper. This groundbreaking research provides unprecedented insights into skin formation and the mechanisms behind various skin disorders. The atlas reveals the molecular 'recipe' for building skin and highlights the immune regulation of human skin morphogenesis. This advancement is expected to pave the way for future skin transplants, treatments for congenital conditions, and potentially scarless skin healing. The study represents a significant leap forward in dermatology and regenerative medicine.
View original story
Similar markets
Pfizer • 25%
Roche • 25%
Novartis • 25%
Other • 25%
Pfizer • 25%
Merck • 25%
Roche • 25%
Other • 25%
Pfizer • 25%
Roche • 25%
Novartis • 25%
Other • 25%
Pfizer • 25%
Merck • 25%
Roche • 25%
Other • 25%
Roche • 25%
Novartis • 25%
Pfizer • 25%
Other • 25%
Pfizer • 25%
Moderna • 25%
Johnson & Johnson • 25%
Other • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Pfizer • 25%
Moderna • 25%
AstraZeneca • 25%
Other • 25%
Pfizer • 25%
Merck • 25%
Johnson & Johnson • 25%
Other • 25%